"Cancer Partners of Nebraska (formerly Southeast Nebraska Cancer Center) provides comprehensive cancer care by combining advanced medical oncology, radiation oncology and several other support services. Our goal is to provide Lincoln and Southeast Nebraska with high-quality, evidence-based cancer care in a compassionate environment."

During the past decade, Southeast Nebraska Cancer Center - 68th Street Place conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 51 clinical trials were completed, i.e. on average, 102% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 28 clinical trials were completed. i.e. 215.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeast Nebraska Cancer Center - 68th Street Place" #1 sponsor was "National Cancer Institute (NCI)" with 34 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "Novartis Pharmaceuticals" with 7 trials sponsored and "Bristol-Myers Squibb" with 7 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeast Nebraska Cancer Center - 68th Street Place" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Sanofi" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Southeast Nebraska Cancer Center - 68th Street Place" are "Breast Cancer" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Multiple Myeloma" (5 trials) and "Recurrent Melanoma" (4 trials). Many other conditions were trialed in "Southeast Nebraska Cancer Center - 68th Street Place" in a lesser frequency.

Most popular intervention types in "Southeast Nebraska Cancer Center - 68th Street Place" are "Drug" (96 trials), "Other" (51 trials), "Biological" (39 trials), "Procedure" (14 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (26 trials), "Quality-of-Life Assessment" (18 trials), "Nivolumab" (15 trials), "Docetaxel" (13 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "Southeast Nebraska Cancer Center - 68th Street Place" are 101 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Southeast Nebraska Cancer Center - 68th Street Place". undefined are not yet recruiting, 20 are recruiting, 45 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Southeast Nebraska Cancer Center - 68th Street Place, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Southeast Nebraska Cancer Center - 68th Street Place, 4 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".